Literature DB >> 23335370

The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment.

Adrienne M Dorrance1, Serena De Vita, Maria Radu, Pavankumar N G Reddy, Meaghan K McGuinness, Chad E Harris, Ronald Mathieu, Steven W Lane, Rachelle Kosoff, Michael D Milsom, Jonathan Chernoff, David A Williams.   

Abstract

The p21-activated kinases (Paks) are serine/threonine kinases that are major effectors of the Rho guanosine 5'\x{2011}triphosphatase, Rac, and Cdc42. Rac and Cdc42 are known regulators of hematopoietic stem and progenitor cell (HSPC) function, however, a direct role for Paks in HSPCs has yet to be elucidated. Lin(-)Sca1(+)c-kit(+) (LSK) cells from wild-type mice were transduced with retrovirus expressing Pak inhibitory domain (PID), a well-characterized inhibitor of Pak activation. Defects in marrow homing and in vitro cell migration, assembly of the actin cytoskeleton, proliferation, and survival were associated with engraftment failure of PID-LSK. The PID-LSK demonstrated decreased phosphorylation of extracellular signal-regulated kinase (ERK), whereas constitutive activation of ERK in these cells led to rescue of hematopoietic progenitor cell proliferation in vitro and partial rescue of Pak-deficient HSPC homing and engraftment in vivo. Using conditional knock-out mice, we demonstrate that among group A Paks, Pak2(-/-) HSPC show reduced homing to the bone marrow and altered cell shape similar to PID-LSK cells in vitro and are completely defective in HSPC engraftment. These data demonstrate that Pak proteins are key components of multiple engraftment-associated HSPC functions and play a direct role in activation of ERK in HSPCs, and that Pak2 is specifically essential for HSPC engraftment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335370      PMCID: PMC3612857          DOI: 10.1182/blood-2012-10-460709

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  The genetics of Pak.

Authors:  Clemens Hofmann; Mikhail Shepelev; Jonathan Chernoff
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

Review 2.  A tale of two Paks.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Biol Cell       Date:  2008-02       Impact factor: 4.458

Review 3.  Lymphocyte homing and homeostasis.

Authors:  E C Butcher; L J Picker
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

4.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

5.  Group I and II mammalian PAKs have different modes of activation by Cdc42.

Authors:  Yohendran Baskaran; Yuen-Wai Ng; Widyawilis Selamat; Felicia Tay Pei Ling; Ed Manser
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

6.  A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein-related FXR1.

Authors:  Evonne Say; Hwee-Goon Tay; Zhuo-shen Zhao; Yohendran Baskaran; Rong Li; Louis Lim; Ed Manser
Journal:  Mol Cell       Date:  2010-04-23       Impact factor: 17.970

7.  p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.

Authors:  Hoi Yee Chow; Dina Stepanova; Jennifer Koch; Jonathan Chernoff
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation.

Authors:  J A Frost; A Khokhlatchev; S Stippec; M A White; M H Cobb
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

9.  Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.

Authors:  Craig W Menges; Eleonora Sementino; Jacqueline Talarchek; Jinfei Xu; Jonathan Chernoff; Jeffrey R Peterson; Joseph R Testa
Journal:  Mol Cancer Res       Date:  2012-07-12       Impact factor: 5.852

10.  Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells.

Authors:  Hee-Don Chae; Katherine E Lee; David A Williams; Yi Gu
Journal:  Blood       Date:  2007-12-18       Impact factor: 22.113

View more
  22 in total

1.  PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.

Authors:  Paolo Neviani; Jason G Harb; Joshua J Oaks; Ramasamy Santhanam; Christopher J Walker; Justin J Ellis; Gregory Ferenchak; Adrienne M Dorrance; Carolyn A Paisie; Anna M Eiring; Yihui Ma; Hsiaoyin C Mao; Bin Zhang; Mark Wunderlich; Philippa C May; Chaode Sun; Sahar A Saddoughi; Jacek Bielawski; William Blum; Rebecca B Klisovic; Janelle A Solt; John C Byrd; Stefano Volinia; Jorge Cortes; Claudia S Huettner; Steffen Koschmieder; Tessa L Holyoake; Steven Devine; Michael A Caligiuri; Carlo M Croce; Ramiro Garzon; Besim Ogretmen; Ralph B Arlinghaus; Ching-Shih Chen; Robert Bittman; Peter Hokland; Denis-Claude Roy; Dragana Milojkovic; Jane Apperley; John M Goldman; Alistair Reid; James C Mulloy; Ravi Bhatia; Guido Marcucci; Danilo Perrotti
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Rho GTPases control specific cytoskeleton-dependent functions of hematopoietic stem cells.

Authors:  Ramesh C Nayak; Kyung-Hee Chang; Nataraja-Sarma Vaitinadin; Jose A Cancelas
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 3.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  Perivascular deletion of murine Rac reverses the ratio of marrow arterioles and sinusoid vessels and alters hematopoiesis in vivo.

Authors:  Marioara F Ciuculescu; Shin-Young Park; Kimberly Canty; Ronald Mathieu; Leslie E Silberstein; David A Williams
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

5.  Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization.

Authors:  Rachelle E Kosoff; Joseph E Aslan; John C Kostyak; Essel Dulaimi; Hoi Yee Chow; Tatiana Y Prudnikova; Maria Radu; Satya P Kunapuli; Owen J T McCarty; Jonathan Chernoff
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

6.  Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiation.

Authors:  Yi Zeng; Hal E Broxmeyer; Karl Staser; Brahmananda Reddy Chitteti; Su-Jung Park; Seongmin Hahn; Scott Cooper; Zejin Sun; Li Jiang; XianLin Yang; Jin Yuan; Rachelle Kosoff; George Sandusky; Edward F Srour; Jonathan Chernoff; D Wade Clapp
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

7.  A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target.

Authors:  Mathilde Gavillet; Kimberly Martinod; Raffaele Renella; Denisa D Wagner; David A Williams
Journal:  Am J Hematol       Date:  2017-12-06       Impact factor: 10.047

8.  p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway.

Authors:  Maria Radu; Karen Lyle; Klaus P Hoeflich; Olga Villamar-Cruz; Hartmut Koeppen; Jonathan Chernoff
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

9.  Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

Authors:  Dimitrios Papaioannou; Changxian Shen; Deedra Nicolet; Betina McNeil; Marius Bill; Malith Karunasiri; Matthew H Burke; Hatice Gulcin Ozer; Selen A Yilmaz; Nina Zitzer; Gregory K Behbehani; Christopher C Oakes; Damian J Steiner; Guido Marcucci; Bayard L Powell; Jonathan E Kolitz; Thomas H Carter; Eunice S Wang; Krzysztof Mrózek; Carlo M Croce; Michael A Caligiuri; Clara D Bloomfield; Ramiro Garzon; Adrienne M Dorrance
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

10.  Pak2 regulates myeloid-derived suppressor cell development in mice.

Authors:  Yi Zeng; Seongmin Hahn; Jessica Stokes; Emely A Hoffman; Monika Schmelz; Maria Proytcheva; Jonathan Chernoff; Emmanuel Katsanis
Journal:  Blood Adv       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.